Asia’s virus busters

Mr Adar Poonawalla: Helping poorer countries level up in access to vaccines

Mr Adar Poonawalla, chief executive of Serum Institute of India, the world's largest vaccine manufacturer. It has started off by producing 40 million doses of the vaccine being developed by Oxford University and AstraZeneca. The vaccine will retail f
Mr Adar Poonawalla, chief executive of Serum Institute of India, the world's largest vaccine manufacturer. It has started off by producing 40 million doses of the vaccine being developed by Oxford University and AstraZeneca. The vaccine will retail for US$3 (S$4) to US$4 per dose for government procurement and US$5 to US$6 for direct private sales. PHOTO: REUTERS
New: Gift this subscriber-only story to your friends and family

Mr Adar Poonawalla gave himself a head start in the race to produce a Covid-19 vaccine.

In April, Mr Poonawalla, 39, announced that his company, Serum Institute of India, the world's largest vaccine manufacturer, would start cranking out vaccine doses being developed by the University of Oxford and the global biopharma company AstraZeneca.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Straits Times on December 05, 2020, with the headline Mr Adar Poonawalla: Helping poorer countries level up in access to vaccines. Subscribe